Value Deepens for Medtech Stocks Hosted by Laycee KluinNovember 3, 2023 ShareLink copied to clipboard. Play video for Value Deepens for Medtech StocksDetailsGuestsResults from Johnson & Johnson and Abbott Laboratories foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units. Based on procedure volume data and the outlook for procedure growth, both companies should continue producing solid results over the next few years, which goes for the industry at large. Because the MedTech stocks are beaten up with a chance of outperforming consensus estimates, and many are trading at significant or critical support levels, a reversal looks imminent for the MedTech market.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioJNJJohnson & Johnson4.692 of 5 stars$173.40+1.1%3.00%18.55ABTAbbott Laboratories4.9102 of 5 stars$134.41+1.8%1.76%16.84ISRGIntuitive Surgical4.9316 of 5 stars$470.08+0.1%N/A65.56BAXBaxter International4.8324 of 5 stars$23.67+0.6%2.87%-78.91MDTMedtronic4.621 of 5 stars$92.94+1.9%3.06%25.67SYKStryker4.928 of 5 stars$377.73+0.4%0.89%50.03 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Listen to MarketBeat Other Platforms Recent Videos Featured Articles and Offers3 Stocks Riding the AI Data Center Buildout WaveAugust 6, 2025View 3 Stocks Riding the AI Data Center Buildout WaveMusk’s Project Colossus could mint millionairesFrom Brownstone Research(Ad)View Musk’s Project Colossus could mint millionaires3 AI Infrastructure Stocks Powering the Next Tech RevolutionAugust 8, 2025View 3 AI Infrastructure Stocks Powering the Next Tech RevolutionAnalysts Make a Quantum Bet on D-Wave's Cryogenic Packaging August 4, 2025View Analysts Make a Quantum Bet on D-Wave's Cryogenic Packaging AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?August 4, 2025View AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?REVEALED FREE: Our top 3 stocks to own in 2025 and beyondFrom Weiss Ratings(Ad)View REVEALED FREE: Our top 3 stocks to own in 2025 and beyond Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinNovember 3, 2023 ShareLink copied to clipboard. Play video for Value Deepens for Medtech StocksDetailsGuestsResults from Johnson & Johnson and Abbott Laboratories foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units. Based on procedure volume data and the outlook for procedure growth, both companies should continue producing solid results over the next few years, which goes for the industry at large. Because the MedTech stocks are beaten up with a chance of outperforming consensus estimates, and many are trading at significant or critical support levels, a reversal looks imminent for the MedTech market.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioJNJJohnson & Johnson4.692 of 5 stars$173.40+1.1%3.00%18.55ABTAbbott Laboratories4.9102 of 5 stars$134.41+1.8%1.76%16.84ISRGIntuitive Surgical4.9316 of 5 stars$470.08+0.1%N/A65.56BAXBaxter International4.8324 of 5 stars$23.67+0.6%2.87%-78.91MDTMedtronic4.621 of 5 stars$92.94+1.9%3.06%25.67SYKStryker4.928 of 5 stars$377.73+0.4%0.89%50.03 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored
